Identification and validation of a novel signature for prediction the prognosis and immunotherapy benefit in bladder cancer

BACKGROUND: Bladder cancer (BC) is a common urinary tract system tumor with high recurrence rate and different populations show distinct response to immunotherapy. Novel biomarkers that can accurately predict prognosis and therapeutic responses are urgently needed. Here, we aim to identify a novel p...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yichi, Lin, Yifeng, Lv, Daojun, Wu, Xiangkun, Li, Wenjie, Wang, Xueqing, Jiang, Dongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2022
Materias:
Bioinformatics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796709/
https://www.ncbi.nlm.nih.gov/pubmed/35127296
http://dx.doi.org/10.7717/peerj.12843

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796709/
https://www.ncbi.nlm.nih.gov/pubmed/35127296
http://dx.doi.org/10.7717/peerj.12843

Ejemplares similares